Models of Research Collaboration to Support the Self-Reliance of Indonesia’s Pharmaceutical Industry

Abstract

Promoting a self-reliant pharmaceutical industry constitutes one of the national strategic agendas. The government undertakes efforts toward self-sufficiency to strengthen health resilience and advance Indonesia’s economic transformation. This policy paper aims to formulate an integrated research collaboration model designed to enhance research and development capacity, increase domestic production capability, and reduce dependence on imported pharmaceutical raw materials and products. The research methodology encompasses an analysis of relevant policies and regulations, a comparative study of three countries considered to have more advanced pharmaceutical sectors, and a mapping of key actors and interaction mechanisms within the pharmaceutical research and innovation ecosystem. The problem identification findings indicate that current challenges include limited inter-institutional coordination, weak technology transfer mechanisms, and the suboptimal alignment between research funding and incentives with industry needs. This policy paper further finds that a primary prerequisite for mission-oriented research collaboration is the presence of a jointly agreed strategic vision among stakeholders, supported by collaborative funding schemes and adaptive intellectual property governance arrangements. The resulting policy recommendations emphasize the need to strengthen the role of the state as an orchestrator of collaboration and to ensure closer integration between research initiatives and pharmaceutical industrialization policies.

References

Abrol, D., & Singh, N. (2019). Indian Pharmaceutical Industry. Development with Global Value Chains: Upgrading and Innovation in Asia, 279.

Akbar, H., & Zaman, S. U. (2025). Innovation Dynamic Performance in the Pharmaceutical Industry: A Study on Establishing a Generic Strategic Planning. Journal of Business and Management Research, 4(2), 95-131.

Al-Jayyousi, O., Amin, H., Al-Saudi, H. A., Aljassas, A., & Tok, E. (2023). Mission-oriented innovation policy for sustainable development: A systematic literature review. Sustainability, 15(17), 13101.

Calza, F., Ferretti, M., Panetti, E., & Parmentola, A. (2021). Moving drug discoveries beyond the valley of death: the role of innovation ecosystems. European Journal of Innovation Management, 24(4), 1184-1209.

Castelnovo, P., & Florio, M. (2020). Mission-oriented public organizations for knowledge creation. In The Routledge handbook of state-owned enterprises (pp. 587-604). Routledge.

Celis, J. E., & Heitor, M. (2019). Towards a mission‐oriented approach to cancer in Europe: an unmet need in cancer research policy. Molecular oncology, 13(3), 502-510.

Ellwood, P., Williams, C., & Egan, J. (2022). Crossing the valley of death: Five underlying innovation processes. Technovation, 109, 102162.

Etzkowitz, H. and L. Leydesdorff (2000), ‘The Dynamics of Innovation: From National Systems and Mode 2 to a Triple Helix of University–Industry–Government Relations’, Research Policy, 29(2), pp. 109–23.

Herder, M. (2006). The Rhetoric of Innovation. LLM Thesis, Dalhousie University.

Hudson, J., & Khazragui, H. F. (2013). Into the valley of death: research to innovation. Drug discovery today, 18(13-14), 610-613.

Jütting, M. (2020). Exploring mission-oriented innovation ecosystems for sustainability: Towards a literature-based typology. Sustainability, 12(16), 6677.

Loggers, J. C. J., Reinders, M. E. J., van Gelder, T., van der Horst, V. M., Bischoff, K. M. S. L., & Guchelaar, H. J. (2025). Academic–industry collaboration in biomedical innovation: A multi-model review of barriers and facilitators. Drug Discovery Today, 104560.

O’Dwyer, M., Filieri, R., & O’Malley, L. (2023). Establishing successful university–industry collaborations: barriers and enablers deconstructed. The Journal of Technology Transfer, 48(3), 900-931.

Odebunmi, K. (2025). Implications of national tax policy on local pharmaceutical production in a southwestern state nigeria–qualitative research for the intersection of national pharmaceutical policy on health systems development. BMC Health Services Research.

Pratistha, B. (2022). Business model innovation in research and development: State of the art and based on public needs. The Journal of Indonesia Sustainable Development Planning, 3(1), 14-29.

Puliga, G. (2019). The impact of Big Science through industry-research collaborations (Doctoral dissertation, LIUC-Universita Carlo Cattaneo (Italy)).

Sawant, R., & Kumar, S. (2025). Collaboration among Industry, Academia, and Government to Fuel Innovative Drug Discovery Research. Journal of Medicinal Chemistry, 68(23), 24725-24729.

Shawar, Y. R., Neill, R., Kunnuji, M., Manoj, M., & Shiffman, J. (2023). Understanding resilience, self-reliance and increasing country voice: a clash of ideologies in global health. BMJ Global Health, 8(1).

Villani, E., Rasmussen, E., & Grimaldi, R. (2017). How intermediary organizations facilitate university–industry technology transfer: A proximity approach. Technological forecasting and social change, 114, 86-102.

Wang, X. (2023). Research on the coupling coordination degree of triple helix of government guidance, industrial innovation and scientific research systems: Evidence from China. Sustainability, 15(6), 4892.

Watkins, A., Papaioannou, T., Mugwagwa, J., & Kale, D. (2015). National innovation systems and the intermediary role of industry associations in building institutional capacities for innovation in developing countries: A critical review of the literature. Research policy, 44(8), 1407-1418.

Wirtz, V. J., Hogerzeil, H. V., Gray, A. L., Bigdeli, M., de Joncheere, C. P., Ewen, M. A., ... & Reich, M. R. (2017). Essential medicines for universal health coverage. The Lancet, 389(10067), 403-476.

World Health Organization. (2024). Application of the essential public health functions: an integrated and comprehensive approach to public health. World Health Organization.

Xia, N. (2025). Pharmaceutical industry influence, traditional medical knowledge, and the evolution of ip governance in china. In Medicinal Mandates: The Intersection of Chinese Traditional Medical Knowledge and Modern Law (pp. 159-201). Singapore: Springer Nature Singapore.

Yudhoyono, A. H., Sukoco, B. M., Maharani, I. A. K., Putra, I. K., & Suhariadi, F. (2025). Bridging the gap: Indonesia’s research trajectory and national development through a scientometric analysis using SciVal. Journal of Open Innovation: Technology, Market, and Complexity.